Evidence map›Paper›PMID 35286924›Full record

ArticleEuropean journal of cell biology2022

HS1 deficiency protects against sepsis by attenuating neutrophil-inflicted lung damage.

Idaira M Guerrero-Fonseca, Alexander García-Ponce, Eduardo Vadillo, Nathaniel L Lartey, Hilda Vargas-Robles, Sandra Chánez-Paredes, Ramón Castellanos-Martínez, Porfirio Nava, Abigail Betanzos, Brittany M Neumann and 3 more

Open access · goldAbstract read
In one paragraph

Article in European journal of cell biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. [Emerging roles of neutrophils in the prognosis of colorectal cancer].Revista medica del Instituto Mexicano del Seguro Social · 2024
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Idaira M Guerrero-FonsecaDepartment of Molecular Biomedicine, CINVESTAV-IPN, Avenida IPN 2508, 07360 Mexico City, Mexico.
Alexander García-PonceDepartment of Molecular Biomedicine, CINVESTAV-IPN, Avenida IPN 2508, 07360 Mexico City, Mexico.
Eduardo VadilloDepartment of Molecular Biomedicine, CINVESTAV-IPN, Avenida IPN 2508, 07360 Mexico City, Mexico.
Nathaniel L LarteyDepartment of Molecular Biomedicine, CINVESTAV-IPN, Avenida IPN 2508, 07360 Mexico City, Mexico.
Hilda Vargas-RoblesDepartment of Molecular Biomedicine, CINVESTAV-IPN, Avenida IPN 2508, 07360 Mexico City, Mexico.
Sandra Chánez-ParedesDepartment of Molecular Biomedicine, CINVESTAV-IPN, Avenida IPN 2508, 07360 Mexico City, Mexico.
Ramón Castellanos-MartínezDepartment of Molecular Biomedicine, CINVESTAV-IPN, Avenida IPN 2508, 07360 Mexico City, Mexico.
Porfirio NavaDepartment of Physiology, Biophysics and Neurosciences, CINVESTAV-IPN, Avenida IPN 2508, 07360 Mexico City, Mexico.
Abigail BetanzosDepartment of Infectomics and Molecular Pathogenesis, CINVESTAV-IPN, Avenida IPN 2508, 07360 Mexico City, Mexico; Conacyt, Mexico City, Mexico.
Brittany M NeumannBrown University Warren Alpert Medical School, Division of Surgical Research, Rhode Island Hospital, Providence, RI, USA.
Kinga Penkala-AugusteBrown University Warren Alpert Medical School, Division of Surgical Research, Rhode Island Hospital, Providence, RI, USA.
Craig T LefortBrown University Warren Alpert Medical School, Division of Surgical Research, Rhode Island Hospital, Providence, RI, USA.
Michael SchnoorDepartment of Molecular Biomedicine, CINVESTAV-IPN, Avenida IPN 2508, 07360 Mexico City, Mexico. Electronic address: mschnoor@cinvestav.mx.
Center for Research and Advanced Studies of the National Polytechnic Institute · MXBrown University · US

Funding

Brown Respiratory Research Training ProgramT32HL134625 · NHLBI · BROWN UNIVERSITY · PI Elizabeth O Harrington, Sharon Irene Smith Rounds · 2017 to 2026
$5.1M
Selective Modulation of Neutrophils in Critical IllnessR35GM124911 · NIGMS · RHODE ISLAND HOSPITAL · PI CRAIG THOMAS LEFORT · 2017 to 2026
$3.8M
Short-Term Training Program to Increase Diversity in Health-Related ResearchR25HL088992 · NHLBI · BROWN UNIVERSITY · PI ABID, RUHUL, DIAZ, JOSEPH A · 2007 to 2024
$1.9M
NHLBI NIH HHS R25 HL088992NHLBI NIH HHS T32 HL134625NIGMS NIH HHS R35 GM124911
6 · The paper itself

Abstract

Sepsis remains an important health problem worldwide due to inefficient treatments often resulting in multi-organ failure. Neutrophil recruitment is critical during sepsis. While neutrophils are required to combat invading bacteria, excessive neutrophil recruitment contributes to tissue damage due to their arsenal of molecular weapons that do not distinguish between host and pathogen. Thus, neutrophil recruitment needs to be fine-tuned to ensure bacterial killing, while avoiding neutrophil-inflicted tissue damage. We recently showed that the actin-binding protein HS1 promotes neutrophil extravasation; and hypothesized that HS1 is also a critical regulator of sepsis progression. We evaluated the role of HS1 in a model of lethal sepsis induced by cecal-ligation and puncture. We found that septic HS1-deficient mice had a better survival rate compared to WT mice due to absence of lung damage. Lungs of septic HS1-deficient mice showed less inflammation, fibrosis, and vascular congestion. Importantly, systemic CLP-induced neutrophil recruitment was attenuated in the lungs, the peritoneum and the cremaster in the absence of HS1. Lungs of HS1-deficient mice produced significantly more interleukin-10. Compared to WT neutrophils, those HS1-deficient neutrophils that reached the lungs had increased surface levels of Gr-1, ICAM-1, and L-selectin. Interestingly, HS1-deficient neutrophils had similar F-actin content and phagocytic activity, but they failed to polymerize actin and deform in response to CXCL-1 likely explaining the reduced systemic neutrophil recruitment in HS1-deficient mice. Our data show that HS1 deficiency protects against sepsis by attenuating neutrophil recruitment to amounts sufficient to combat bacterial infection, but insufficient to induce tissue damage.

Indexed as

NeutrophilsSepsisAnimalsDisease Models, AnimalLungMiceMice, Inbred C57BLNeutrophil InfiltrationActin dynamicsCortactinDiapedesisHCLSInflammationNeutrophil extravasation

Identifiers

PMID35286924
PMCPMC10170315
OpenAlexW4220912650

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.